Crossmark

Adverse drug reactions to chloroquine/hydroxychloroquine in combination with azithromycin in COVID-19 in-patients: data from intensive pharmacovigilance in Morocco, 2020

Crossref DOI link: https://doi.org/10.1007/s00210-023-02574-7

Published Online: 2023-06-26

Published Print: 2023-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aït Moussa, Latifa https://orcid.org/0000-0001-9016-8445
Tebaa, Amina https://orcid.org/0000-0002-1976-1075
Alj, Loubna https://orcid.org/0000-0001-5464-378X
Sefiani, Houda https://orcid.org/0000-0003-2938-3183
Meski, Fatima Zahra https://orcid.org/0000-0002-4296-0574
Khattabi, Asmae https://orcid.org/0000-0001-5194-996X
Soulaymani Bencheikh, Rachida https://orcid.org/0000-0002-3764-3523
License Information

Text and Data Mining valid from 2023-06-26

Version of Record valid from 2023-06-26
More Information

Article History

Received: 30 January 2023

Accepted: 12 June 2023

First Online: 26 June 2023

Declarations

:

: This is an observational study. The health authority of the Centre Anti Poison et de Pharmacovigilance du Maroc has confirmed that no ethical approval is required since the ADRs reports were considered to be standards of care and all data were analyzed anonymously.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below